Aero Hygenx is a leading expert in the fight against pathogens and has worked with world-renowned organizations and institutions to study the impact of UV-C on surfaces and electronics.
We are the first company worldwide to have our portable UV-C disinfection solutions approved for use in the fight against pathogens by Health Canada and RAY is the first and only product included in a brand new category of Health Canada’s Safe Product Registry.
Our UV-Xposure Lab is capable of simulating years’ worth of exposure in a matter of hours*, allowing experts to assess the impact of UV-C exposure over time almost immediately. UV-C exposure is directly proportional to the energy of light received over time.
With the demand for UV-C disinfection solutions growing exponentially, so has the demand for transparent, reliable impact data. Aero HygenX’s innovative in-house UV-Xposure Lab provides impact assessments for any and all surfaces, materials and electronics.
Regulatory bodies and independent certification authorities require accurate data in order to assess the potential impact of UV-C exposure on materials and electronics. Our UV-Xposure Lab provides this data.
Launched in 2020, Aero HygenX is the brainchild of a team of expert engineers, safety officers, software developers and quality management professionals united by their passion for travel and a shared desire to see the transportation industry recover from the effects of the COVID-19 pandemic. Lab Testing Includes: Live-streaming of the exposure, video conferencing to discuss procedures, start- and stop the exposures. Immediately accessible results for transmissibility testing, and Custom UV-C exposure parameters, including:
Material exposure time is tested as part of our UV-C exposure parameters.
We test the intensity of light as part of our UV-C exposure parameters.
The wavelength of UV-C light (222nm | 254nm | 280nm) is always tested.
Aero HygenX has collaborated with the National Research Institute of Canada, the National Institute of Aviation Research (Wichita, Kansas) and Western University (London, Ontario) to prove our products’ efficacy against resilient pathogens, including the SARS-CoV 2 virus and its variants, Adenovirus, and Methicillin-Resistant Staphylococcus Aureus (MRSA).
Exposed materials are then sent back to our customers where they can be analyzed and undergo any further impact testing including, for example: